3 ms·
This is nothing new and is the process by which insurance companies reduce drug costs. Insurers come up with formularies that favor less expensive drugs first.
by refurb 7y ago
This is nothing new and is the process by which insurance companies reduce drug costs.
Insurers come up with formularies that favor less expensive drugs first. If those don’t work, the patient can get the more expensive drugs.
Manufacturers negotiate formulary agreements. They might offer a rebate to move their product to first line use.
In therapeutic areas like psoriasis, the rebates can exceed 50% since it’s such a competitive class with more than a dozen products.
- techsupporter 7y agoThis absolutely is new, or at least the use of PBMs in this way has greatly expanded. When I was in the insurance business, formularies were very common, as I imagine they still are based on my experience as a customer of an insurance plan. Whether or not a drug was on the formulary list was both knowable in advance and negotiable. If your doctor wanted to prescribe something to you that wasn't on your plan's list and had a good reason and felt like having his or her staff spend an hour on the phone once a quarter, your insurance company would often permit it. Funny enough, Anthem--discussed in the article--was one of the better ones in the past about having flexible formulary rules. Even if your doctor wanted to go off-label with an unlisted drug, the majority of insurers would cover it in some way. This use of PBMs, where drugs are on the formulary list but the doctor is told "nope, you can't prescribe that right now or in this way or in this quantity" and being overruled by a pharmacist at the insurer, is relatively new and scary. (Incidentally, this is why the rhetoric of "death panels" during the debate around the Affordable Care Act was bullshit. We've always rationed care in this country and, in the private insurance market, how it is rationed is almost always completely opaque.)
- darkerside 7y agoWhat's new is the application of step therapy to cancer care. Per the article, this was introduced into Medicare by HHS under the Trump administration.
- refurb 7y agoThat’s true, cancer was generally unmanaged in the past. However, some control is needed. I was talking to an insurer once and he mentioned a doctor who had prescribed a drug for patient where there was no evidence it worked. When he asked the doctor why, he said “well I have to give them something”. This was a $10,000 per month drug.